28.8 C
New York
Sunday, June 14, 2026

Tag: committee

Optiva Inc. Reports Second Quarter 2025 Financial Results

All amounts are stated in United States dollars unless otherwise indicated

AUTOCANADA APPOINTS FELIX-ETIENNE LEBEL TO BOARD OF DIRECTORS

EDMONTON, AB, Aug. 13, 2025 /CNW/ - AutoCanada Inc. ("AutoCanada" or the "Company") (TSX: ACQ), a multi-location North American automobile dealership group, is pleased...

MDU Resources Announces Appointments to the Board of Directors

BISMARCK, N.D., Aug. 13, 2025 /PRNewswire/ -- MDU Resources Group, Inc. (NYSE: MDU) today announced the election of Charles M. Kelley and Tammy J....

MSA Safety Names Julie A. Beck Senior Vice President, Chief Financial Officer and Treasurer

PITTSBURGH, Aug. 13, 2025 /PRNewswire/ -- MSA Safety Incorporated (NYSE: MSA), a global leader in the development of advanced safety products and solutions that...

Wedbush Securities Welcomes William Floyd as a Financial Consultant in Dallas, Texas

William Floyd joins Wedbush's Wealth Management division as a Financial Consultant in Dallas, TX.

Notice of convening the General Meeting of Shareholders of AB “Ignitis grupė”

On 13 August 2025, the Management Board of AB “Ignitis grupė” (hereinafter – the Group or AB “Ignitis grupė”), legal entity code: 301844044, registered office address: Laisvės Ave. 10, Vilnius, decided to convene the General Meeting of Shareholders (hereinafter – GM) of the Group.

Notice of convening the General Meeting of Shareholders of AB “Ignitis grupė”

On 13 August 2025, the Management Board of AB “Ignitis grupė” (hereinafter – the Group or AB “Ignitis grupė”), legal entity code: 301844044, registered office address: Laisvės Ave. 10, Vilnius, decided to convene the General Meeting of Shareholders (hereinafter – GM) of the Group.

Diversified Provides Board of Directors Update

Diversified Provides Board of Directors Update

Sapiens to be acquired by Advent for $2.5 Billion

Sapiens shareholders to receive $43.50 per share in cash, a 64% premium to Sapiens' undisturbed closing share price of $26.52 on August 8, 2025  KEY...

KBP’s Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration

SINGAPORE, Aug. 13, 2025 /PRNewswire/ -- KBP Biosciences Pte. Ltd. (the "Company") today issued a statement addressing a further decision by the Singapore International...

FPT Corporation Strengthens Vietnam-Korea Partnerships in Semiconductors and High-Quality Workforce Training

SEOUL, South Korea, Aug. 12, 2025 /PRNewswire/ -- Within the framework of the Vietnam–Korea Economic Forum 2025, and in the presence of Prime Minister of...

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

VICTORIA, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced its financial results for the second quarter of 2025 and provided a business update. All dollar values are in U.S. dollars unless stated otherwise.

Theravance Biopharma, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

YUPELRI® (revefenacin) net sales of $66.3 million, recognized by Viatris, increased 22% year-over-year1Pivotal Phase 3 CYPRESS study enrollment on track to complete by late...

5 Pew-Stewart Scholars Selected to Pursue Pioneering Cancer Research

PHILADELPHIA, Aug. 12, 2025 /PRNewswire/ -- The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced today the 2025 class of the...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCommittee